Increased Extrapyramidal Symptoms with Addition of Lithium to Neuroleptics
- 1 November 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 176 (11) , 682-685
- https://doi.org/10.1097/00005053-198811000-00006
Abstract
To explore whether lithium exacerbates neuroleptic-induced extrapyramidal symptoms (EPS), the authors prospectively rated 10 patients on neuroleptics before and after the addition of lithium. EPS ratings increased steadily after the initiation of lithium and were significantly elevated compared with baseline. Individual items that increased significantly were: gait, shoulder shaking, elbow rigidity, and tremor. These findings indicate that usual therapeutic levels of lithium may significantly worsen neuroleptic-induced EPS. Potential mechanisms for this interaction are discussed.This publication has 3 references indexed in Scilit:
- Lithium prevents adaptation of brain dopamine systems to haloperidol in schizophrenic patientsPsychiatry Research, 1983
- Essential hypertension and membrane lithium transport in depressed patientsPsychiatry Research, 1983
- Effect of neuroleptic drugs on lithium uptake by the human erythrocyteClinical Pharmacology & Therapeutics, 1979